We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AVTE market cap is 74.35M. The company's latest EPS is USD -2.6155 and P/E is -0.98.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -17.64M | -20.34M | -21.37M | -22.07M | -24.62M |
Net Income | -16.52M | -19.03M | -19.56M | -20.41M | -23.19M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.33M | -8.89M | -23.02M | -53.24M | -81.41M |
Net Income | -3.33M | -9.61M | -22.96M | -51.51M | -75.52M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 124.39M | 155.76M | 140.88M | 127.42M | 106.82M |
Total Liabilities | 11.3M | 13.83M | 15.15M | 17.96M | 15.92M |
Total Equity | 113.1M | 141.93M | 125.72M | 109.46M | 90.9M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.51M | 4.72M | 175.36M | 135.3M | 127.42M |
Total Liabilities | 657k | 1.77M | 2.95M | 8.56M | 17.96M |
Total Equity | -3.64M | -13.34M | 172.42M | 126.74M | 109.46M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -11.42M | -60.54M | -41.98M | -56.78M | -23.67M |
Investing | 15.38M | 19.36M | 6.23M | 11.88M | 8.83M |
Financing | 223k | 45.51M | 45.53M | 46M | 471k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2.78M | -7.86M | -27.4M | -39.12M | -56.78M |
Investing | N/A | N/A | -113.43M | 6.93M | 11.88M |
Financing | 2.5M | 8.92M | 190.46M | 396k | 46M |
Market Cap | 74.35M |
Price to Earnings Ratio | -0.98 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.16 |
Price to Book Ratio | 0.68 |
Dividend Yield | - |
Shares Outstanding | 28.87M |
Average Volume (1 week) | 123.79k |
Average Volume (1 Month) | 259.68k |
52 Week Change | -83.89% |
52 Week High | 32.415 |
52 Week Low | 1.25 |
Spread (Intraday) | 0.01 (0.39%) |
Company Name | Aerovate Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aerovatetx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions